Seeking Alpha

Synta Pharmaceuticals (SNTA +3.6%) trades up after saying it's entered into stock purchase...

Synta Pharmaceuticals (SNTA +3.6%) trades up after saying it's entered into stock purchase agreements with members of its Board and various institutional investors to sell 7M shares of its common stock in an issuer directed, registered direct offering. Shares were priced at $8.60, yesterday's closing bid price. Gross proceeds from the sale were approximately $60M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector